Improving Post-Prandial Blood Glucose Control With Afrezza During Closed-Loop Therapy
NCT03234491
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Post-Prandial Hyperglycemia
Post-Prandial Hypoglycemia
Interventions
DEVICE:
DiAS
DRUG:
Afrezza low dose
DRUG:
Afrezza high dose
Sponsor
Yale University